Second Trimester Testing in US Exhibits Augmented Growth

Press Release   •   Jul 31, 2012 15:02 IST

According to a new research report by RNCOS entitled, “Prenatal Testing Market Outlook 2015”, second trimester prenatal testing is conducted during 15-18 weeks of pregnancy to check the levels of several biomarkers and detect fetal chromosomal aneuploidies. The market for such tests is growing primarily, due to the high incidences of chromosomal abnormalities and the need for accurate detection. Late pregnancies have become an increasing driver for such testing as they represent the high-risk population. Government initiatives to recommend second trimester screening a part of regular check-ups to all age groups is expected to boost the market further.

Prenatal testing consists of prenatal screening tests, prenatal diagnostic tests, and tests related to Preimplantation genetic diagnosis (PGD). The prenatal testing industry is at the juncture of evolution and demands greater insights in the regulatory scenario, cost effectiveness of various testing methodologies and penetration to all strata of the population. Amongst the market segments, while the market for first and second trimester testing is expected to evolve further, the popularity of invasive techniques, such as CVS and amniocentesis is expected to witness a decline. According to the latest report by RNCOS, “Prenatal Testing Market Outlook 2015”, high and further rising, the US prenatal testing market was valued at US$ 1.8 Billion in 2010.

The report which is spread in over 35 pages provides an in-depth research and rational analysis of the current and expected status of the prenatal testing market in US. The report provides an understanding of the major prenatal tests involved in US for both screening and diagnostic purposes.  The current and future forecasts for each market segment have been presented to provide the market progress in the coming years along with expected growth in the overall industry. Prevailing industry trends and drivers have also been compiled. A section on regulatory scenario analysis has also been provided in the report. Key competitor analysis also provides an understanding of the major players and their portfolio of testing services provided for prenatal testing.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM415.htm

Some of our Related Reports are:

- US Nutraceuticals Market Analysis (http://www.rncos.com/Report/IM350.htm)
- China Healthcare Market Forecast to 2015 (http://www.rncos.com/Report/IM409.htm)
- Saudi Arabian Healthcare Forecast to 2015(http://www.rncos.com/Report/IM386.htm)
- UAE Healthcare Sector Forecast to 2014 (http://www.rncos.com/Report/IM387.htm)
- US Healthcare IT Market Forecast to 2014 (http://www.rncos.com/Report/IM390.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.